Publications database

This resource presents data from hospitals participating in the European Drug Emergencies Network (Euro-DEN — Euro-DEN Plus) project. The Euro-DEN project involves the collection of data on emergency department presentations with acute...

This report examines the role of Europe in the production and trafficking of captagon tablets. It includes an historical background, current production and trafficking, seizures, the consumer market, production within the EU...

The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains...

Heroin remains Europe’s most commonly used illicit opioid and is also the drug responsible for a large share of the health burden attributed to illicit drug consumption. Europe’s opioid problem, however, has...

Alongside the more well-known substances available on illicit drugs markets, a number of other substances with hallucinogenic, anaesthetic, dissociative or depressant properties are used in Europe: these include LSD, hallucinogenic mushrooms, ketamine...

The market for new psychoactive substances is characterised by the large number of substances that have appeared in this area and that new compounds continue to be detected each year. On this...

The markets for hexahydrocannabinol (HHC) and related semi-synthetic cannabinoids (SSC) are rapidly evolving areas with relatively limited information currently available. The European situation presented in Section 1 can only provide an overview...

This interactive timeline highlights some of the key achievements and milestones over the last 25 years of monitoring new psychoactive substances in Europe.

The purpose of this report is to examine the current situation, risks and responses to the recreational use of nitrous oxide in Europe. To support this, the report also provides a state-of-the-art...

This poster, presented during the IX International Conference on NPS (24 to 26 Oct 2022, Panama), showcases some of the work of the EU Early Warning System on new psychoactive substances. Operated...